Skip to main content

Table 3 Univariate and multivariate Cox regression of clinicopathological features and infiltrating immune cells for overall survival

From: Comparison of the prognostic value of stromal tumor-infiltrating lymphocytes and CD3 + T cells between schistosomal and non-schistosomal colorectal cancer

Variable

All patients (N = 314)

NSCRC (N = 188)

SCRC (N = 126)

p

HR (95% CI)

p

HR (95% CI)

p

HR (95% CI)

Univariate analysis

 sTILs

0.000

0.553 (0.398–0.769)

0.002

0.499 (0.321–0.776)

0.162

0.704 (0.431–1.151)

 iTILs

0.497

1.413 (0.521–3.831)

0.949

1.047 (0.256–4.281)

0.201

2.533 (0.609–10.546)

 CD3*

0.001

0.478 (0.307–0.745)

0.012

0.518 (0.309–0.868)

0.014

0.318 (0.127–0.796)

 CD20*

0.007

0.613 (0.428–0.877)

0.029

0.600 (0.379–0.950)

0.044

0.573 (0.333–0.985)

 Age (< 60 years)

0.013

1.731 (1.124–2.666)

0.156

1.410 (0.877–2.268)

0.232

21.827 (0.139–3436.270)

 Gender (male/female)

0.013

1.562 (1.100–2.216)

0.022

1.738 (1.082–2.790)

0.307

1.311 (0.779–2.207)

 Tumor size (5 cm)

0.834

1.036 (0.746–1.437)

0.526

0.864 (0.550–1.357)

0.320

1.282 (0.786–2.089)

Tumor site

 Rectum

 

Refer

 

Refer

 

Refer

 Left colon

0.908

1.025 (0.676–1.553)

0.677

0.891 (0.516–1.537)

0.539

1.229 (0.636–2.376)

 Right colon

0.501

0.869 (0.578–1.307)

0.054

0.587 (0.341–1.010)

0.128

1.636 (0.867–3.084)

 Pathological T stage

0.000

2.596 (1.565–4.307)

0.001

3.375 (1.625–7.008)

0.087

1.851 (0.915–3.747)

 Lymph node metastasis

0.000

2.793 (2.002–3.895)

0.000

2.469 (1.581–3.856)

0.000

3.552 (2.141–5.894)

 TNM stage

0.000

3.216 (2.279–4.537)

0.000

2.797 (1.765–4.434)

0.000

4.219 (2.479–7.128)

 Tumor differentiation

0.000

1.879 (1.326–2.662)

0.003

2.013 (1.260–3.216)

0.054

1.668 (0.991–2.809)

 Lymphangio

0.000

2.038 (1.467–2.832)

0.000

2.829 (1.811–4.419)

0.275

1.321 (0.801–2.180)

 Nervous invasion

0.143

1.492 (0.873–2.552)

0.327

1.417 (0.706–2.844)

0.500

1.727 (0.741–4.024)

 Tumor deposit

0.000

3.979 (2.667–5.936)

0.000

3.967 (2.353–6.688)

0.000

4.138 (2.205–7.769)

 Colonic perforation

0.813

0.887 (0.328–2.397)

0.767

1.190 (0.375–3.670)

0.508

0.506 (0.070–3.657)

 Tumor budding (≤ 5 cells)

0.001

1.877 (1.297–2.715)

0.000

2.500 (1.492–4.188)

0.421

1.247 (0.729–2.134)

 Schistosomiasis

0.049

1.390 (1.001–1.929)

 Ulceration

0.617

0.919 (0.659–1.281)

0.743

1.077 (0.690–1.681)

0.212

0.725 (0.437–1.201)

 Histological type

0.705

1.096 (0.683–1.757)

0.280

1.403 (0.759–2.594)

0.467

0.760 (0.362–1.594)

Multivariate analysis

 Gender

0.001

1.886 (1.295–2.746)

0.021

1.812 (1.093–3.004)

 

 TNM stage

0.000

2.099 (1.403–3.139)

0.000

3.703 (2.149–6.381)

 Tumor budding (≤ 5 cells)

0.050

1.647 (0.988–2.745)

 Tumor differentiation

0.039

1.499 (1.021–2.203)

0.021

1.826 (1.095–3.044)

 

 CD3*

0.003

0.481 (0.297–0.781)

0.026

0.525 (0.297–0.927)

0.045

0.404 (0.160–1.021)

 sTILs

0.031

0.660 (0.452–0.963)

0.034

0.570 (0.339–0.959)

 Lymphangio

0.012

1.580 (1.106–2.256)

0.006

1.994 (1.223–3.252)

 Tumor deposit

0.000

2.818 (1.743–4.555)

0.000

3.837 (2.053–7.170)

  1. —Data is non-significant; Abbreviation: NSCRC Non-schistosomal colorectal cancer, SCRC Schistosomal colorectal cancer, HR Hazard ratio, CI Confidence interval, sTILs stromal tumor-infiltrating lymphocytes, iTILs intratumoral-infiltrating lymphocytes, P < 0.05 was defined as the criterion for variable deletion when performing backward stepwise selection
  2. *Missing data (although 349 CRC patients were enrolled in the cohort, some sample tissues were unavailable for the immunohistochemical assay, such as those with high-fat content. Finally, there were 314 cases could be used for the following analysis of CD3 and CD20)